Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2026-02-21 @ 4:08 AM
Study NCT ID:
NCT03944369
Status:
TERMINATED
Last Update Posted:
2021-01-22
First Post:
2019-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant Organisms
Sponsor:
Kaleido Biosciences
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized … | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Microbiome | View |
| None | Antibiotic resistance | View |
| None | Carbapenem-Resistant Enterobacteriaceae (CRE) | View |
| None | Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae (ESBLE) | View |
| None | Vancomycin-resistant Enterococcus (VRE) | View |
| None | Multi Drug Resistant Organism (MDRO) | View |
| None | Drug resistant | View |
| None | Kaleido | View |
| None | VITORA | View |
| None | KB109 | View |
| None | Microbiome Metabolic Therapy (MMT) | View |
| None | Oligosaccharide | View |
| None | Glycan | View |